JP2022554395A5 - - Google Patents

Info

Publication number
JP2022554395A5
JP2022554395A5 JP2022526337A JP2022526337A JP2022554395A5 JP 2022554395 A5 JP2022554395 A5 JP 2022554395A5 JP 2022526337 A JP2022526337 A JP 2022526337A JP 2022526337 A JP2022526337 A JP 2022526337A JP 2022554395 A5 JP2022554395 A5 JP 2022554395A5
Authority
JP
Japan
Application number
JP2022526337A
Other languages
Japanese (ja)
Other versions
JP2022554395A (ja
JPWO2021092436A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/059476 external-priority patent/WO2021092436A1/en
Publication of JP2022554395A publication Critical patent/JP2022554395A/ja
Publication of JP2022554395A5 publication Critical patent/JP2022554395A5/ja
Publication of JPWO2021092436A5 publication Critical patent/JPWO2021092436A5/ja
Pending legal-status Critical Current

Links

JP2022526337A 2019-11-08 2020-11-06 がんを処置するためのスプライシング由来抗原の同定 Pending JP2022554395A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962932751P 2019-11-08 2019-11-08
US62/932,751 2019-11-08
US201962934914P 2019-11-13 2019-11-13
US62/934,914 2019-11-13
PCT/US2020/059476 WO2021092436A1 (en) 2019-11-08 2020-11-06 Identification of splicing-derived antigens for treating cancer

Publications (3)

Publication Number Publication Date
JP2022554395A JP2022554395A (ja) 2022-12-28
JP2022554395A5 true JP2022554395A5 (https=) 2023-11-14
JPWO2021092436A5 JPWO2021092436A5 (https=) 2023-11-14

Family

ID=75849568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022526337A Pending JP2022554395A (ja) 2019-11-08 2020-11-06 がんを処置するためのスプライシング由来抗原の同定

Country Status (5)

Country Link
US (1) US20220380937A1 (https=)
EP (1) EP4055182A4 (https=)
JP (1) JP2022554395A (https=)
CN (1) CN115968406A (https=)
WO (1) WO2021092436A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020144021A1 (en) * 2019-01-09 2020-07-16 British Telecommunications Public Limited Company Anomalous behaviour detection in a distributed transactional database
JP2023513605A (ja) * 2020-02-14 2023-03-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア がんを処置するためのスプライシング由来抗原を含む組成物および方法
EP4423116A4 (en) * 2021-10-25 2025-12-17 Univ California METHODS AND COMPOSITIONS FOR THE TREATMENT OF GLIOBLASTOM
EP4201954A1 (en) * 2021-12-22 2023-06-28 Christian-Albrechts-Universität zu Kiel Proteins and t-cells involved in chronic inflammatory diseases
US20250277013A1 (en) * 2022-05-04 2025-09-04 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts T cell receptor derived binding polypeptides
CN114891885A (zh) * 2022-05-04 2022-08-12 重庆大学附属肿瘤医院 Hdhd5-as1长链非编码rna水平检测试剂在制备卵巢癌干性诊断试剂中的应用
WO2024044786A2 (en) * 2022-08-26 2024-02-29 H. Lee Moffitt Cancer Center And Research Institute, Inc. Novel cd4+ tumor infiltrating lymphocytes for the treatment of cancer
US20260027153A1 (en) * 2023-01-17 2026-01-29 The Regents Of The University Of California Therapeutic polynucleotides encoding t cell receptor (tcr) alpha chain polypeptides and/or tcr beta chain polypeptides
WO2025050009A2 (en) * 2023-09-01 2025-03-06 Children's Hospital Medical Center Identification of targets for immunotherapy in melanoma using splicing-derived neoantigens

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8021658B2 (en) * 2001-05-25 2011-09-20 Thomas Jefferson University Alternative splice forms of proteins as basis for multiple therapeutic modalities
AU2013243948A1 (en) * 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
CN118750591A (zh) * 2013-04-07 2024-10-11 博德研究所 用于个性化瘤形成疫苗的组合物和方法
KR101503341B1 (ko) * 2014-03-12 2015-03-18 국립암센터 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법
US10130693B2 (en) * 2015-08-28 2018-11-20 Immatics Biotechnologies Gmbh Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
KR20260039788A (ko) * 2017-10-10 2026-03-20 시애틀 프로젝트 코포레이션 핫스팟을 이용한 신생항원 동정
JP2023513605A (ja) * 2020-02-14 2023-03-31 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア がんを処置するためのスプライシング由来抗原を含む組成物および方法

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)